Tisch Cancer Institute Icahn School of Medicine at Mount Sinai
New York, New York, United States
Michal Bar-Natan, MD, is an Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mt. Sinai, an Attending Physician with the Center of Excellence for Blood Cancers and Myeloid Disorders, and the leader of the Acute Lymphoblastic Leukemia program at the Mt. Sinai Tisch Cancer Institute. Her focus is on translational research in malignant hematology, particularly myeloid malignancies and acute lymphoblastic leukemia, and the development of investigator-initiated clinical trials in patients with these conditions.
Dr. Bar-Natan graduated cum laude from Sackler School of Medicine. She completed her Internal Medicine Residency at Sheba Medical Center and her Fellowship in Hematology and Medical Oncology at NYU Langone health. In addition to her clinical fellowship training, Dr. Bar-Natan completed a research fellowship at Dana Farber Cancer Institute and Brigham and Women’s Hospital with a focus on the role that signal transducer and activator of transcription (STAT) proteins play in the development and treatment of myeloproliferative neoplasms and leukemias.
Dr. Bar-Natan leads early phase clinical trials implementing new therapeutic approaches, such as immunotherapies and combination therapies, and serve as the PI and co-investigator on many clinical trials for acute leukemia and myeloproliferative neoplasm.
Disclosure information not submitted.
Wednesday, October 19, 2022
9:05 AM – 10:10 AM
Wednesday, October 19, 2022
9:30 AM – 9:50 AM
Wednesday, October 19, 2022
9:50 AM – 10:10 AM